BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19195685)

  • 1. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
    Heylen E; Miljic P; Willemse J; Djordjevic V; Radojkovic D; Colovic M; Elezovic I; Hendriks D
    Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages.
    Matus V; Willemse J; Quiroga T; Goycoolea M; Aranda E; Panes O; Pereira J; Hendriks D; Mezzano D
    Clin Chim Acta; 2009 Mar; 401(1-2):158-61. PubMed ID: 19038242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
    Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
    Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
    Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma procarboxypeptidase U in men with symptomatic coronary artery disease.
    Silveira A; Schatteman K; Goossens F; Moor E; Scharpé S; Strömqvist M; Hendriks D; Hamsten A
    Thromb Haemost; 2000 Sep; 84(3):364-8. PubMed ID: 11019956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial thrombophilia and the prothrombin 20210A mutation: association with increased thrombin generation and unusual thrombosis.
    Eikelboom JW; Ivey L; Ivey J; Baker RI
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):1-5. PubMed ID: 10070829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic prothrombotic risk factors in women with unexplained pregnancy loss.
    Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammì C; Santoro R; Iannaccaro P; Muleo G; Lombardo VT
    Thromb Res; 2006; 117(6):681-4. PubMed ID: 16014310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.
    Bombeli T; Basic A; Fehr J
    Am J Hematol; 2002 Jun; 70(2):126-32. PubMed ID: 12111785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan.
    Obeidat NM; Awidi A; Sulaiman NA; Abu-Khader IB
    Saudi Med J; 2009 Jul; 30(7):921-5. PubMed ID: 19618008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred.
    Bovill EG; Hasstedt SJ; Callas PW; Valliere JE; Scott BT; Bauer KA; Long GL
    Thromb Haemost; 2000 Mar; 83(3):366-70. PubMed ID: 10744139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.